Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

10:17
 
Share
 

Manage episode 391681631 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

Show notes
(00:32)
Could you please provide us a little information about your background?

(01:46)
Could you please give the audience a brief overview of this assay?

(03:45)
Which patients should have this testing and when should it be performed?

(06:39)
How are the results used in patient care?

(08:51)
What alternative test options are available and how do they compare to our test?

  continue reading

308 episodes

Artwork
iconShare
 
Manage episode 391681631 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

Show notes
(00:32)
Could you please provide us a little information about your background?

(01:46)
Could you please give the audience a brief overview of this assay?

(03:45)
Which patients should have this testing and when should it be performed?

(06:39)
How are the results used in patient care?

(08:51)
What alternative test options are available and how do they compare to our test?

  continue reading

308 episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide